Institut Claude Pompidou - Centre Mémoire de Ressources et de Recherche du CHU de Nice
Nice, Alpes-Maritime, 06100, France
NCT Number: NCT04041089
Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the spatial location of objects, their manipulation and/or recognition. Its etiology is most often neurodegenerative, with a major impact on the autonomy and mood of patients and their families. Few studies have focused on non-medication management of these disorders.
The present study thus has a double objective: the development of a complete tool to work on the recognition, localization and/or manipulation of objects; and the evaluation of the effectiveness of this type of management.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Nice, Alpes-Maritime, 06100, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At week 34
Effectiveness will be evaluated a score based on success rate (from 0 to 10), reaction time and eye-recording .
Centre Hospitalier Universitaire de Nice
Other
Development and Evaluation of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy (PCA)
Acronym: REEDUC-ACP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01095744
Alzheimer Disease, Alzheimer's Disease
Paris, Île-de-France Region, France
View Trial DetailsNCT03153371
Alzheimer Disease, Alzheimer Disease, Early Onset
Los Angeles, California, United States
View Trial DetailsNCT07191327
Posterior Cortical Atrophy
Ann Arbor, Michigan, United States
View Trial DetailsNCT04150198
Alzheimer Disease, Alzheimer Disease, Early Onset
Orsay, France
View Trial Details